Sarcoma and gastrointestinal stromal tumour (GIST)

Explore our latest news, features and educational resources in this specialist area.

Regulatory alerts NICE guidance

Regulatory Alerts, Sarcoma and gastrointestinal stromal tumour (GIST), Oncology Room

Avapritinib not recommended for unresectable or metastatic gastrointestinal stromal tumours

Avapritinib not deemed cost-effective, according to NICE draft guidance.

Oct 27, 2020

Cancer/testis antigens expression during cultivation of melanoma and soft tissue sarcoma cells

Oncology – Journal Spy

Oncology, Sarcoma and gastrointestinal stromal tumour (GIST)

Cancer/testis antigens expression during cultivation of melanoma and soft tissue sarcoma cells

Jan 22, 2020

Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre

Oncology – Journal Spy

Oncology, Sarcoma and gastrointestinal stromal tumour (GIST)

Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre

Jan 04, 2020